EGFR and hepatocellular carcinoma: Furthermore, B4GALT1 interacts directly with EGFR inhibiting the dimerization of the receptor and the tyrosine phosphorylation and its activation in human hepatocellular carcinoma cells, suggesting an inhibitory role of B4GALT1 in EGFR signaling pathway [28,29].